Intravitreal moxifloxacin in treatment of postcataract endophthalmitis

Abstract

Postcataract endophthalmitis is a well-known and feared complication that might lead to a devastating outcome for the diseased eye. A case of postcataract extraction endophthalmitis treated with an intravitreal moxifloxacin injection prepared from commercially available preservative-free topical eyedrops (Vigamox), achieving 20/20 corrected distance visual acuity posttreatment is reported. A 70-year-old woman was found to have endophthalmitis in the left eye with hand motion vision on day 8 postcataract extraction. Accordingly, tap-and-inject procedure was performed using 0.05 mL of 0.5% moxifloxacin aspirated directly from a sealed eyedrop bottle and injected intravitreally. Forty-eight hours later, a similar second injection was given. The patient improved progressively and reached 20/20 vision 2 months later.